More big wins for the AstraZeneca-Daiichi Sankyo collaboration
This month has seen two groundbreaking approvals for Enhertu, which is developed and marketed by AstraZeneca and Daiichi Sankyo.
By
GlobalData Healthcare
Latest articles
All Articles
Implementation of electronic health records will improve the quality of care
Electronic health records (EHRs) are expected to drive big changes in the provision of healthcare and clinical research delivery.
By
Governments and pharma relationships and implications for antimicrobial resistance
To overcome the growing threat posed by antimicrobial resistance, a variety of approaches must be taken.
By
Schizophrenia trials continue to test drug candidates as Covid-19 pandemic continues
A total of 127 planned schizophrenia clinical trials are planned to be held over the coming years.
By
Covid-19 Omicron boosters will reinvigorate injectables manufacturing
Once new vaccines for the Omicron variant are approved, they will partly make up for the waning interest in…
By
Despite benefits, long-acting injectables remain underutilised for schizophrenia
Resistance surrounding the use of long-acting injectables in schizophrenia remains, resulting in lower-than-anticipated uptake.
By
Current and future players in the osteoarthritis market
The current standards of care in osteoarthritis focus on symptom management and are made up of generic pharmaceuticals.
By
Age-related macular degeneration market expected to grow to $22.8bn in 2031
The AMD market is projected to grow strongly over the next nine years, but there are potential barriers to…
By
Late-stage ulcerative colitis pipeline continues to innovate
The pipeline for ulcerative colitis remains strong with many novel mechanisms of action and new routes of administration.
By